Journal Logo

December 27, 1998 - Volume 66 - Issue 12
pp: 1567-1846


SYNERGISTIC EFFECTS OF MYCOPHENOLATE MOFETIL AND SIROLIMUS IN PREVENTION OF ACUTE HEART, PANCREAS, AND KIDNEY ALLOGRAFT REJECTION AND IN REVERSAL OF ONGOING HEART ALLOGRAFT REJECTION IN THE RAT1,2

Vu, Minh Diem; Qi, Shijie; Xu, Dasheng; More

Transplantation. 66(12):1575-1580, December 27, 1998.

LONG-TERM COMPOSITE TISSUE ALLOGRAFT SURVIVAL IN A PORCINE MODEL WITH CYCLOSPORINE/MYCOPHENOLATE MOFETIL THERAPY1,2

Üstüner, E. Tuncay; Zdichavsky, Marty; Ren, Xiaoping; More

Transplantation. 66(12):1581-1587, December 27, 1998.


CENTRAL NERVOUS SYSTEM LESIONS IN LIVER TRANSPLANT RECIPIENTS: Prospective Assessment of Indications for Biopsy and Implications for Management1

Bonham, C. Andrew; Dominguez, Edward A.; Fukui, Melanie B.; More

Transplantation. 66(12):1596-1604, December 27, 1998.

PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1

McDiarmid, Sue V.; Jordan, Stan; Lee, Geoffrey S.; More

Transplantation. 66(12):1604-1611, December 27, 1998.

RANDOMIZED TRIAL OF CYCLOSPORINE MICROEMULSION (NEORAL) VERSUS CONVENTIONAL CYCLOSPORINE IN LIVER TRANSPLANTATION: MILTON Study1,2

Otto, Max-Gerd; Mayer, A. David; Clavien, Pierre-Alain; More

Transplantation. 66(12):1632-1640, December 27, 1998.

SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1

Green, Michael; Cacciarelli, Thomas V.; Mazariegos, George V.; More

Transplantation. 66(12):1641-1644, December 27, 1998.

PROGNOSIS AFTER PRIMARY RENAL TRANSPLANT FAILURE AND THE BENEFICIAL EFFECTS OF REPEAT TRANSPLANTATION: Multivariate Analyses from the United States Renal Data System1,2

Ojo, Akinlolu O.; Wolfe, Robert A.; Agodoa, Lawrence Y.; More

Transplantation. 66(12):1651-1659, December 27, 1998.

A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1

Flechner, Stuart M.; Avery, Robin K.; Fisher, Rosemaree; More

Transplantation. 66(12):1682-1688, December 27, 1998.

TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS1

Bryan, Christopher F.; Shield, Charles F. III; Nelson, Paul W.; More

Transplantation. 66(12):1714-1717, December 27, 1998.

RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR Fc FUSION PROTEIN THERAPY IN KIDNEY TRANSPLANT RECIPIENTS UNDERGOING OKT3 INDUCTION THERAPY1,2

Novak, Erik J.; Blosch, Consuelo M.; Perkins, James D.; More

Transplantation. 66(12):1732-1735, December 27, 1998.

HISTOLOGIC GRADING OF ACUTE ALLOGRAFT REJECTION IN PANCREAS NEEDLE BIOPSY: Correlation to Serum Enzymes, Glycemia, and Response to Immunosuppressive Treatment1

Papadimitriou, John C.; Drachenberg, Cinthia B.; Wiland, Anne; More

Transplantation. 66(12):1741-1745, December 27, 1998.

COMBINED HEART AND KIDNEY TRANSPLANTATION USING A SINGLE DONOR: A Single Center's Experience with Nine Cases1

Kocher, Alfred A.; Schlechta, Bernhard; Kopp, Christoph W.; More

Transplantation. 66(12):1760-1763, December 27, 1998.

EFFECT OF ORAL ACYCLOVIR OR GANCICLOVIR THERAPY AFTER PREEMPTIVE INTRAVENOUS GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE ANTIBODY THERAPY1

Turgeon, Nathalie; Fishman, Jay A.; Basgoz, Nesli; More

Transplantation. 66(12):1780-1786, December 27, 1998.



LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1

Bryan, Christopher F.; Baier, Karen A.; Nelson, Paul W.; More

Transplantation. 66(12):1827-1832, December 27, 1998.


Clinical Transplantation


Immunobiology



Show: